Pages that link to "Q38795736"
The following pages link to Molecular alterations in apoptotic pathways after PKB/Akt-mediated chemoresistance in NCI H460 cells (Q38795736):
Displaying 13 items.
- Role of Akt signaling in resistance to DNA-targeted therapy (Q28066950) (← links)
- Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer (Q28396304) (← links)
- Hypoxia-induced cytotoxic drug resistance in osteosarcoma is independent of HIF-1Alpha (Q28533909) (← links)
- Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells. (Q33569013) (← links)
- 17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells (Q33688498) (← links)
- Akt versus p53 in a network of oncogenes and tumor suppressor genes regulating cell survival and death (Q35023909) (← links)
- Inauhzin sensitizes p53-dependent cytotoxicity and tumor suppression of chemotherapeutic agents (Q36801098) (← links)
- Elevated inorganic phosphate stimulates Akt-ERK1/2-Mnk1 signaling in human lung cells (Q37098613) (← links)
- Mitomycin C treatment induces resistance and enhanced migration via phosphorylated Akt in aggressive lung cancer cells (Q37694878) (← links)
- The Emerging Role of Extracellular Vesicle-Mediated Drug Resistance in Cancers: Implications in Advanced Prostate Cancer (Q38639852) (← links)
- Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells (Q40399507) (← links)
- PROM2 promotes gemcitabine chemoresistance via activating the Akt signaling pathway in pancreatic cancer (Q89983732) (← links)
- DNAH10 mutation correlates with cisplatin sensitivity and tumor mutation burden in small-cell lung cancer (Q92782244) (← links)